Inventor
Xiaoshan MIN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
C07KPeptides28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
Y02ATechnologies for adaptation to climate change11%
C12NMicroorganisms or enzymes6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
PatentTitleYear
12,435,149Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists202512,252,540Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)202511,965,029ST2 antigen binding proteins202411,919,953TIGIT and CD112R blockade202411,739,131Growth differentiation factor 15 (GDF-15) polypeptides2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to AMGEN INC (5)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 5 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2025 |